D115 Unit 2: Genetic Testing and Disorders – Cohort Notes

Student Name

Western Governors University 

D115 Advanced Pathophysiology for the Advanced Practice Nurse

Prof. Name

Date

Unit 2: Genetic Testing and Genetic Disorders

Genetic Testing Overview

Genetic testing refers to a broad range of laboratory-based techniques designed to analyze DNA, RNA, chromosomes, proteins, or metabolites in order to identify genetic variations associated with disease susceptibility, diagnosis, prognosis, and therapeutic response. Advances in molecular biology and genomic technologies have significantly enhanced the ability to detect both single-gene disorders and complex multifactorial conditions influenced by genetic and environmental factors. As a result, genetic testing has become a cornerstone of modern healthcare, supporting preventive medicine, informed reproductive planning, early disease detection, and personalized treatment strategies.

Genetic testing also plays a critical role in public health by enabling population-based screening programs, reducing disease burden, and improving long-term health outcomes through early intervention.

Types of Genetic Testing

What Is Carrier Screening?

Carrier screening is a genetic testing approach used to identify individuals who carry one mutated allele of a gene associated with an autosomal recessive disorder. Although carriers typically do not present with clinical symptoms, they have the potential to transmit the mutation to their offspring. When both parents are carriers of the same condition, there is a 25% chance that their child will be affected.

Carrier screening is particularly valuable for individuals planning a family and is often recommended for populations with a higher prevalence of specific inherited disorders. Expanded carrier screening panels now allow simultaneous testing for multiple conditions, increasing detection rates and improving reproductive decision-making.

Common Disorders Detected Through Carrier Screening

Through carrier screening, couples are empowered with genetic risk information, allowing them to explore reproductive options such as prenatal testing, in vitro fertilization with genetic screening, or the use of donor gametes.

What Is Prenatal Diagnosis?

Prenatal diagnosis involves genetic testing performed during pregnancy to evaluate the genetic status of the developing fetus. It is recommended for all pregnant individuals, particularly those with advanced maternal age, abnormal prenatal screening results, known genetic disorders in the family, or a history of pregnancy complications.

The primary goal of prenatal diagnosis is to identify chromosomal abnormalities or inherited genetic conditions early in gestation, enabling timely counseling, informed decision-making, and appropriate medical planning.

Common Prenatal Diagnostic Techniques

These diagnostic tools vary in invasiveness, timing, and risk, but collectively they provide essential insights into fetal health.

What Is Presymptomatic Genetic Testing?

Presymptomatic genetic testing identifies individuals who carry genetic mutations associated with late-onset disorders before clinical symptoms appear. Common examples include mutations in the BRCA1 and BRCA2 genes linked to hereditary breast and ovarian cancer, as well as genes associated with familial colorectal cancer.

Early identification allows individuals to adopt preventive strategies such as enhanced surveillance, prophylactic surgery, and lifestyle modifications, thereby reducing morbidity and mortality.

What Is Pharmacogenetic Testing?

Pharmacogenetic testing examines genetic variations that influence drug metabolism, efficacy, and toxicity. Differences in genes encoding drug-metabolizing enzymes, transporters, or drug targets can significantly affect therapeutic outcomes.

By integrating pharmacogenetic data into clinical practice, healthcare providers can tailor drug selection and dosing to individual genetic profiles, improving treatment effectiveness while minimizing adverse drug reactions.

Reasons for Genetic Screening

Genetic screening thus supports proactive healthcare delivery and improves patient-centered outcomes.

Chromosomal Aneuploidy Disorders

Turner Syndrome

What Is Turner Syndrome and How Common Is It?

Turner syndrome is a chromosomal disorder characterized by the partial or complete absence of one X chromosome (45,X) in phenotypic females. It occurs in approximately 1 in 2,500 live female births and was first described by Dr. Henry Turner in 1938.

What Causes Turner Syndrome?

The condition arises from monosomy X or structural abnormalities of one X chromosome. Affected individuals typically exhibit ovarian failure due to gonadal streak formation, resulting in insufficient estrogen and progesterone production. Some individuals display mosaicism, where a mixture of normal and abnormal cell lines exists, often leading to milder clinical manifestations.

What Are the Clinical Features of Turner Syndrome?

How Is Turner Syndrome Diagnosed and Managed?

Diagnosis is confirmed through karyotype analysis. Management includes growth hormone therapy, estrogen replacement, fertility counseling, and lifelong multidisciplinary monitoring to address cardiovascular, metabolic, and skeletal complications.

Klinefelter Syndrome

What Is Klinefelter Syndrome and Its Prevalence?

Klinefelter syndrome is a sex chromosome disorder affecting males who possess one or more extra X chromosomes, most commonly 47,XXY. It affects approximately 1 in 1,000 male births, with symptom severity increasing as the number of extra X chromosomes rises.

What Are the Signs of Klinefelter Syndrome?

Clinical features include hypogonadism, small testes, infertility, gynecomastia, reduced facial and body hair, tall stature, and variable learning difficulties. Individuals with mosaic karyotypes often experience milder symptoms.

Cri du Chat Syndrome (5p Deletion Syndrome)

What Genetic Change Causes Cri du Chat Syndrome?

Cri du Chat syndrome results from a deletion on the short arm of chromosome 5. The severity of symptoms correlates with the size and location of the deleted segment. Most cases occur sporadically, though familial transmission has been reported.

What Are the Key Clinical Features?

Diagnosis is confirmed through cytogenetic or molecular testing. Management is supportive and includes physical, occupational, and speech therapy.

Down Syndrome (Trisomy 21)

What Causes Down Syndrome?

Down syndrome is caused by the presence of an extra copy of chromosome 21, making it the most common autosomal aneuploidy compatible with life. It affects approximately 1 in 800 live births.

What Are the Clinical Characteristics?

Immunity and Genetic Influence

What Constitutes Innate Immunity?

Innate immunity represents the body’s first line of defense and is present from birth. It includes physical barriers such as skin and mucous membranes, mechanical defenses like coughing and urination, biochemical agents including gastric acid and lysozyme, and immune cells such as neutrophils, macrophages, dendritic cells, and natural killer cells. Inflammation is a central feature, characterized by redness, heat, swelling, and pain.

What Is Adaptive Immunity?

Adaptive immunity develops following exposure to pathogens or vaccines and provides highly specific immune responses. It consists of humoral immunity mediated by antibody-producing B lymphocytes and cell-mediated immunity involving T lymphocytes. Immunological memory generated through this process ensures rapid and effective responses upon re-exposure.

Inheritance Patterns of Genetic Disorders

What Are the Main Modes of Genetic Inheritance?

Autosomal dominant disorders require only one mutated allele for disease expression, with a 50% transmission risk to offspring. Huntington’s disease is a well-known example.

Autosomal recessive disorders manifest only when both alleles are mutated, typically inherited from asymptomatic carrier parents. Cystic fibrosis and sickle cell disease are classic examples.

X-linked disorders involve genes located on the X chromosome.

Case Study: Systemic Lupus Erythematosus (SLE)

What Is the Pathophysiology of SLE?

Systemic lupus erythematosus is a chronic autoimmune disorder characterized by the production of antinuclear antibodies. Genetic susceptibility combined with environmental triggers such as ultraviolet radiation leads to immune complex deposition and type III hypersensitivity reactions. These processes result in widespread inflammation and multi-organ involvement.

How Is SLE Diagnosed and Treated?

Diagnosis is based on fulfilling clinical and immunological criteria, including malar rash, arthritis, renal involvement, hematologic abnormalities, and autoantibody detection. Management focuses on controlling disease activity through corticosteroids, immunosuppressive agents, antimalarials, and lifestyle modifications to prevent flare-ups and organ damage.

References

American College of Obstetricians and Gynecologists. (2020). Carrier screening in the age of genomic medicine. ACOG Practice Bulletin.

Centers for Disease Control and Prevention. (2023). Genetic testing and screening.

Kumar, V., Abbas, A. K., & Aster, J. C. (2021). Robbins and Cotran pathologic basis of disease (10th ed.). Elsevier.

National Institutes of Health. (2022). Genetic and rare diseases information center.

Strachan, T., & Read, A. (2018). Human molecular genetics (5th ed.). Garland Science.